Trade Faes Farma, S.A. - FAE CFD
Add to favourite- Summary
- Historical Data
Spread | 0.09 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021418% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000804% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Spain | ||||||||
Commission on trade | 0% |
Prev. Close | 3.64 |
Open | 3.59 |
1-Year Change | 14.7% |
Day's Range | 3.59 - 3.69 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 6, 2024 | 3.66 | 0.07 | 1.95% | 3.59 | 3.69 | 3.59 |
Sep 5, 2024 | 3.64 | 0.08 | 2.25% | 3.56 | 3.67 | 3.55 |
Sep 4, 2024 | 3.61 | 0.04 | 1.12% | 3.57 | 3.62 | 3.56 |
Sep 3, 2024 | 3.63 | 0.01 | 0.28% | 3.62 | 3.66 | 3.59 |
Sep 2, 2024 | 3.64 | -0.03 | -0.82% | 3.67 | 3.68 | 3.60 |
Aug 30, 2024 | 3.69 | 0.06 | 1.65% | 3.63 | 3.71 | 3.63 |
Aug 29, 2024 | 3.67 | 0.05 | 1.38% | 3.62 | 3.67 | 3.62 |
Aug 28, 2024 | 3.64 | 0.10 | 2.82% | 3.54 | 3.65 | 3.54 |
Aug 27, 2024 | 3.55 | 0.00 | 0.00% | 3.55 | 3.64 | 3.55 |
Aug 26, 2024 | 3.61 | 0.01 | 0.28% | 3.60 | 3.63 | 3.55 |
Aug 23, 2024 | 3.55 | -0.03 | -0.84% | 3.58 | 3.63 | 3.55 |
Aug 22, 2024 | 3.53 | -0.05 | -1.40% | 3.58 | 3.64 | 3.53 |
Aug 21, 2024 | 3.62 | 0.03 | 0.84% | 3.59 | 3.62 | 3.56 |
Aug 20, 2024 | 3.62 | 0.00 | 0.00% | 3.62 | 3.65 | 3.60 |
Aug 19, 2024 | 3.63 | 0.09 | 2.54% | 3.54 | 3.64 | 3.54 |
Aug 16, 2024 | 3.61 | 0.02 | 0.56% | 3.59 | 3.62 | 3.56 |
Aug 15, 2024 | 3.61 | 0.05 | 1.40% | 3.56 | 3.61 | 3.55 |
Aug 14, 2024 | 3.57 | 0.01 | 0.28% | 3.56 | 3.58 | 3.53 |
Aug 13, 2024 | 3.58 | 0.03 | 0.85% | 3.55 | 3.58 | 3.55 |
Aug 12, 2024 | 3.51 | -0.01 | -0.28% | 3.52 | 3.60 | 3.44 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Faes Farma Company profile
About FAES Farma SA
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, FAES Farma SA revenues increased 5% to EUR398.6M. Net income increased 15% to EUR83.2M. Revenues reflect Speciality Pharmaceuticals segment increase of 5% to EUR336.8M, Nutrition & Animals Care Products segment increase of 6% to EUR60.3M, Domestic Market (Spain) segment increase of 11% to EUR307.3M. Net income benefited from Provisions decrease of 74% to EUR1.5M (expense).
Equity composition
05/2005, Scrip Issue, 1 new share for every 8 shares held. 03/2006, Scrip Issue, 1 new share for every 8 shares held. 01/2007, 2-for-1 stock split. 04/2007, Scrip Issue, 1 new share for every 8 shares held. 04/2008, Scrip Issue, 1 new share for every 8 shares held. 03/2009, Scrip Issue, 1 new share for every 8 shares held. => Note section
Industry: | Pharmaceuticals (NEC) |
Parque Empresarial Cristalia. Calle Vía de los Poblados 3, Edificio 2, 2º Izquierda
MADRID
MADRID 28033
ES
News
![](https://img.capital.com/imgs/articles/192x130x1/1350x880_-HP-_Newsquawk-light.png)
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024![](https://img.capital.com/imgs/articles/192x130x1/Gold_10.jpg)
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024![](https://img.capital.com/imgs/articles/192x130x1/USUK.jpg)
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024![](https://img.capital.com/imgs/articles/192x130x1/European-stocks_0.jpg)
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024![](https://img.capital.com/imgs/articles/192x130x1/Global-selloff_0.jpg)
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024![](https://img.capital.com/imgs/articles/192x130x1/Graphiccs-1-.png)
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com